.In the 1960s, United States anatomist Leonard Hayflick observed that replicative cells have a limited number of divisions, caused partly by telomere shortening as well as later referred to the Hayflick limitation. He saw that some cells quit portioning but declined to pass away, a process gotten in touch with senescence that has given that been actually implicated in many diseases as well as is actually right now being targeting by biotech as well as pharmaceutical companies.The Clinical Pipeline is actually a cavalcade on translational and professional analysis, from seat to bedside.